Trials Sponsors Conditions Drugs Pricing

Conditions

Shoulder Joint Disorder

Keywords

Shoulder jointsShinbaro pharmacopunctureMegadose shinbaro pharmacopunctureChronic shoulder painShoulder pain

Outcome Measures

Primary Outcomes (1)

Numeric Rating Scale of shoulder pain
The extent of shoulder pain and discomfort was assessed using NRS. NRS is a pain scale in which the patient indicates their subjective pain as a whole number from 0 to 10. The participant is asked to report their shoulder pain and discomfort using NRS, where 0 indicates 'no pain or discomfort' and 10 indicates 'the most severe pain and discomfort imaginable'.
At 2 weeks

Secondary Outcomes (7)

Visual Analogue Scale of shoulder pain
At screening, baseline, 2 weeks and through study completion, an average of 3 month
Shoulder mobility on the Shoulder ROM
At baseline, 2 weeks and through study completion, an average of 3 month
Shoulder Pain and Disability Index questionnaire of shoulder pain and disability
At baseline, 2 weeks, 3 months
Patient Global Impression of Change
At baseline, 2 weeks, 3 months
EuroQol 5-Dimension
At baseline, 2 weeks, 3 months
+2 more secondary outcomes

Study Arms (2)

Megadose Shinbaro Pharmacopuncture Group

The Megadose Shinbaro Pharmacopuncture group who are treated with korean medical treatment including Megadose Shinbaro Pharmacopuncture will be evaluated on first, second, third visit and 2weeks after baseline. And the patients will receive telephone inquires after 3months from the baseline. The Korean medical treatment includes acupuncture, chuna and Korean herbal medicine.

Procedure: Megadose Shinbaro Pharmacopuncture

Control Group

The control group who are treated with Korean medical treatment not including Megadose Shinbaro Pharmacopuncture will be evaluated on first, second, third visit and 2weeks after baseline. And the patients will receive telephone inquires after 3months from the baseline. The Korean medical treatment includes acupuncture, chuna and Korean herbal medicine.

Interventions

Megadose Shinbaro PharmacopunctureProcedure

Pharmacopuncture is a treatment that combines 2 of the most frequented Korean medicine treatment methods - traditional acupuncture and herbal medicine - by injecting herbal medicine extract at acupoints. Shinbaro is a refined herbal formulation used to treat inflamed lesions and bone diseases.

Megadose Shinbaro Pharmacopuncture Group

Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.

Eligibility Criteria

Age19 Years - 70 Years

Sexall

Healthy VolunteersNo

Age GroupsAdult (18-64), Older Adult (65+)

Sampling MethodNon-Probability Sample

Study Population

Patients who are treated in Haeundae Jaseng Korean Medicine Hospital

You may qualify if:

Patients with NRS ≥ 4 for shoulder pain over 3weeks

Sponsors & Collaborators

Jaseng Medical Foundation
Otherlead

Study Sites (1)

Haeundae Jaseng Hospital of Korean Medicine

Busan, 48102, South Korea

MeSH Terms

Conditions

Shoulder Pain

Condition Hierarchy (Ancestors)

ArthralgiaJoint DiseasesMusculoskeletal DiseasesPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

In-Hyuk Ha
Jaseng Medical Foundation
STUDY CHAIR

Enrollment

36 participants (actual enrollment reported by the registry).

Study Design

Study Type: observational
Observational Model: CASE CONTROL
Time Perspective: PROSPECTIVE
Target Duration: 3 Months
Sponsor Type: OTHER
Responsible Party: PRINCIPAL INVESTIGATOR
PI Title: Director

Study Record Dates

First Submitted

January 7, 2020

First Posted

January 10, 2020

Study Start

December 4, 2019

Actual (reported)

Study Stopped

The Effectiveness of Megadose Shinbaro Pharmacopuncture for Patients With Chronic Shoulder Pain

Brief Summary

Registry Overview

Trial Relationships

Study Timeline

Study Start

First Submitted

First Posted

Primary Completion

Study Completion

Conditions

Keywords

Outcome Measures

Primary Outcomes (1)

Secondary Outcomes (7)

Study Arms (2)

Megadose Shinbaro Pharmacopuncture Group

Control Group

Interventions

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Study Sites (1)

MeSH Terms

Conditions

Condition Hierarchy (Ancestors)

Study Officials

Enrollment

Study Design

Study Record Dates

You may not qualify if:

Source record

Locations

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

Study Start

First Submitted

First Posted

Primary Completion

Study Completion

Conditions

Keywords

Outcome Measures

Primary Outcomes (1)

Secondary Outcomes (7)

Study Arms (2)

Megadose Shinbaro Pharmacopuncture Group

Control Group

Interventions

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Study Sites (1)

MeSH Terms

Conditions

Condition Hierarchy (Ancestors)

Study Officials

Enrollment

Study Design

Study Record Dates

You may not qualify if:

Source record

Locations